Note 6 - Share-based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2018 |
Notes Tables |
|
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | (In thousands) | | | (In thousands) | | | | 2018 | | | 2017 | | | 2018 | | | 2017 | | Stock options and SARS | | $ | 16 | | | $ | 345 | | | $ | 960 | | | $ | 1,092 | | Restricted stock | | | 140 | | | | 80 | | | | 404 | | | | 243 | | Performance shares | | | 221 | | | | 121 | | | | 503 | | | | 319 | | Total share-based compensation expense | | $ | 377 | | | $ | 546 | | | $ | 1,867 | | | $ | 1,654 | | | | | | | | | | | | | | | | | | | Related income tax benefit | | $ | 44 | | | $ | 29 | | | $ | 229 | | | $ | 197 | |
|
Share-based Compensation, Stock Options, Activity [Table Text Block] |
| | No. of | | | Weighted Average | | | | Shares | | | Exercise Price | | Outstanding December 31, 2017 | | | 633,877 | | | $ | 13.33 | | Granted | | | 141,630 | | | | 22.20 | | Exercised | | | (60,058 | ) | | | 10.08 | | Lapsed | | | (1,800 | ) | | | 5.88 | | Cancelled | | | (2,620 | ) | | | 20.05 | | Outstanding September 30, 2018 | | | 711,029 | | | $ | 15.36 | |
|
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] |
| | | | | | | | Weighted Average | | | | | | Range of | | | | | | Remaining | | | Weighted Average | | Exercise Price | | Shares | | | Contractual Life (Years) | | | Exercise Price | | $ 3.82 | - | $ 5.88 | | | 89,000 | | | 2.86 | | | $ | 5.33 | | $ 7.36 | - | $10.38 | | | 126,767 | | | 1.55 | | | $ | 7.85 | | $16.35 | - | $18.66 | | | 352,232 | | | 3.15 | | | $ | 17.49 | | $21.63 | - | $24.28 | | | 143,030 | | | 4.58 | | | $ | 23.03 | | | | | | | | | | | | | | | | $ 3.82 | - | $24.28 | | | 711,029 | | | 3.12 | | | $ | 15.36 | |
|
Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity [Table Text Block] |
| | No. of | | | Weighted Average | | | | Shares | | | Exercise Price | | Outstanding December 31, 2017 | | | 146,504 | | | $ | 17.38 | | Granted | | | 48,515 | | | | 23.59 | | Exercised | | | (12,125 | ) | | | 17.92 | | Lapsed | | | - | | | | - | | Cancelled | | | - | | | | - | | Outstanding September 30, 2018 | | | 182,894 | | | $ | 18.99 | |
|
Share-based Compensation, Activity [Table Text Block] |
| | | | | | | | Weighted Average | | | | | | Range of | | | | | | Remaining | | | Weighted Average | | Exercise Price | | Shares | | | Contractual Life (Years) | | | Exercise Price | | $16.35 | - | $18.66 | | | 134,379 | | | 2.33 | | | $ | 17.33 | | $23.59 | - | $23.59 | | | 48,515 | | | 4.33 | | | $ | 23.59 | | | | | | | | | | | | | | | | $16.35 | - | $23.59 | | | 182,894 | | | 2.86 | | | $ | 18.99 | |
|
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] |
Three months ended | | | | | | | | | September 30, | | SARS | | | Options | | | | | | | | | | | Exercise price | | | | | | | | | 2018 | | | N/A | | | $ | 18.86 | | 2017 | | | N/A | | | $ | 21.63 | | | | | | | | | | | Market price | | | | | | | | | 2018 | | | N/A | | | $ | 18.86 | | 2017 | | | N/A | | | $ | 21.63 | | | | | | | | | | | | | | | | | | | | 2018 | | | N/A | | | | 2.7 | % | 2017 | | | N/A | | | | 1.8 | % | | | | | | | | | | Expected award life (years) 2 | | | | | | | | | 2018 | | | N/A | | | | 3 | | 2017 | | | N/A | | | | 5 | | | | | | | | | | | | | | | | | | | | 2018 | | | N/A | | | | 35.4 | % | 2017 | | | N/A | | | | 37.2 | % | | | | | | | | | | | | | | | | | | | 2018 | | | N/A | | | | 2.1 | % | 2017 | | | N/A | | | | 1.8 | % | Nine months ended | | | | | | | | | | | September 30, | | SARS | | | Options | | | | | | | | | | | | | Exercise price | | | | | | | | | | | 2018 | | $ | 23.59 | | | | $18.86 | - | $24.28 | | 2017 | | $ | 16.97 | | | | $16.97 | - | $21.63 | | | | | | | | | | | | | Market price | | | | | | | | | | | 2018 | | $ | 23.59 | | | | $18.86 | - | $24.28 | | 2017 | | $ | 16.97 | | | | $16.97 | - | $21.63 | | | | | | | | | | | | | | | | | | | | | | | | 2018 | | | 2.6 | % | | | 2.6% | - | 2.9% | | 2017 | | | 1.9 | % | | | 1.8% | - | 2.4% | | | | | | | | | | | | | Expected award life (years) 2 | | | | | | | | | | | 2018 | | | 3 | | | | 3 | - | 10 | | 2017 | | | 5 | | | | 5 | - | 10 | | | | | | | | | | | | | | | | | | | | | | | | 2018 | | | 35.4 | % | | | 35.4% | - | 42.1% | | 2017 | | | 36.6 | % | | | 36.6% | - | 41.4% | | | | | | | | | | | | | | | | | | | | | | | | 2018 | | | 1.6 | % | | | 1.6% | - | 2.1% | | 2017 | | | 2.1 | % | | | 1.8% | - | 2.1% | |
|
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] |
| | | | | | Weighted Average | | | | No. of | | | Grant Date | | | | Shares | | | Fair Value | | Outstanding December 31, 2017 | | | 61,378 | | | $ | 17.89 | | Granted | | | 24,908 | | | | 23.56 | | Vested | | | - | | | | - | | Forfeited | | | - | | | | - | | Outstanding September 30, 2018 | | | 86,286 | | | $ | 19.52 | |
|
Schedule of Nonvested Performance-based Units Activity [Table Text Block] |
| | | | | | Weighted Average | | | | No. of | | | Grant Date | | | | Shares | | | Fair Value | | Outstanding December 31, 2017 | | | 118,492 | | | $ | 17.84 | | Granted | | | 84,838 | | | | 24.56 | | Vested | | | - | | | | - | | Forfeited | | | (8,952 | ) | | | 24.98 | | Outstanding September 30, 2018 | | | 194,378 | | | $ | 20.08 | |
|